Joseph Mikhael MD, MEd, FRCPC, FACP

Dr Mikhael is a Professor in the Applied Cancer Research and Drug Discovery Division at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope Cancer Center. He is also the Chief Medical Officer of the International Myeloma Foundation (IMF) and Director of Myeloma research at the HonorHealth Research Institute. Dr Mikhael specializes clinically in plasma cell disorders, namely multiple myeloma, amyloidosis, and Waldenstrom’s macroglobulinemia. He is the PI of many clinical trials, primarily in relapsed multiple myeloma, and his other clinical research interests include pharmaco-economics, communication skills, and media relations. Dr. Mikhael also serves as the Treasurer on the executive of the American Society of Hematology.

Dr Mikhael has published over 150 peer-reviewed articles in these fields and lectures internationally on a regular basis.  Dr. Mikhael is deeply committed to health disparities in myeloma and leads the diversity efforts of the IMF, namely the M-Power project in the African American community.  He is also the chair of the Diversity, Equity and Inclusion Council at TGen.  Dr. Mikhael is heavily involved in training future researchers and mentors junior faculty worldwide.  He also spends nearly 20% of his time in the third world developing collaborations in myeloma and finding ways to enhance access to novel agents.